April 17, 2015
Eli Lily Pharmaceutal Co. persuaded a Texas federal court Thursday to throw out a proposed class action by a woman claiming its antidepressant Cymbalta caused withdrawal symptoms that she said the drugmaker did not sufficiently warn about.